BeOne Medicines (BEIGF) EBITDA Margin Growth (1y) (2016 - 2026)
Powered by 
Analysis
BeOne Medicines (BEIGF) EBITDA Margin Growth (1y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.47 Bn | 624.71 Bn | 17.26 Bn | 22.00 |
| 2 | AbbVie | 439.99 Bn | 433.42 Bn | 12.70 Bn | 613.00 |
| 3 | Merck | 365.45 Bn | 358.31 Bn | 12.21 Bn | -3,510.00 |
| 4 | Novartis Ag | 266.57 Bn | 258.88 Bn | 11.24 Bn | -164.00 |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | -611.00 |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | -572.00 |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - | - |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | -194.00 |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | -341.00 |
| 10 | BeOne Medicines | 2.48 Bn | -2.62 Bn | 1.53 Bn | 1,238.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,238.00 |
| Mar 31, 2026 | 1,552.00 |
| Dec 31, 2025 | 1,939.00 |
| Sep 30, 2025 | 2,356.00 |
| Jun 30, 2025 | 1,821.00 |
| Mar 31, 2025 | 3,576.00 |
| Dec 31, 2024 | 5,345.00 |
| Sep 30, 2024 | 514.00 |
| Jun 30, 2024 | 4,201.00 |
| Mar 31, 2024 | 4,814.00 |
| Dec 31, 2023 | 6,279.00 |
| Sep 30, 2023 | 9,594.00 |
| Jun 30, 2023 | 7,510.00 |
| Mar 31, 2023 | 6,166.00 |
| Dec 31, 2022 | 14,390.00 |
| Sep 30, 2022 | 11,086.00 |
| Jun 30, 2022 | 18,794.00 |
| Mar 31, 2022 | -15,615.00 |
| Dec 31, 2021 | 21,723.00 |
| Sep 30, 2021 | 25,929.00 |